Hanan Sboul takes over the position of IGBA Chair For immediate release Geneva, 7 January 2020 IGBA, the International Generic and Biosimilar medicines Association (IGBA), representing global manufacturers of generic and biosimilar medicines, announced today that Hanan Sboul, Secretary General of the Jordanian Association of Pharmaceutical Manufacturers, is taking over the position of IGBA Chair for 2020 from Jim Keon, President of the Canadian Generic Pharmaceutical Association and Biosimilars Canada. Key milestones were achieved for the IGBA during 2019, namely the signature of a memorandum of understanding with the World Health Organization (WHO) to promote access i and the adoption

In cooperation with JFDA, JAPM held a workshop for members and nonmembers entitled: “Pharmacovigilance in Practice” Speakers from the Rational Dug Use Department/ JFDA covered the following topics: Reporting ADRs Lessons to Be Learned What’s Beyond Safety Agreement Why Collecting Medication Errors, Drug Misuse, Abuse, Overdose, Off Label use Major Deficiencies during PV-Inspection Perceived Impact of RMP & PSUR on the Leaflet Phase IV Studies, Where We Stand? It is worth mentioning that; this workshop comes as a continues cooperation between JAPM and the JFDA to achieve the growth and development of the Jordanian pharmaceutical industry by holding workshops for